Ravinder Kodela

1.9k total citations
48 papers, 1.6k citations indexed

About

Ravinder Kodela is a scholar working on Biochemistry, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ravinder Kodela has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biochemistry, 18 papers in Organic Chemistry and 18 papers in Pharmacology. Recurrent topics in Ravinder Kodela's work include Sulfur Compounds in Biology (17 papers), Inflammatory mediators and NSAID effects (17 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Ravinder Kodela is often cited by papers focused on Sulfur Compounds in Biology (17 papers), Inflammatory mediators and NSAID effects (17 papers) and Eicosanoids and Hypertension Pharmacology (16 papers). Ravinder Kodela collaborates with scholars based in United States, India and Canada. Ravinder Kodela's co-authors include Khosrow Kashfi, Mitali Chattopadhyay, Y. Venkateswarlu, A. Vijender Reddy, Niharika Nath, Daniel Boring, Carlos A. Velázquez‐Martínez, V. L. Niranjan Reddy, V. Ravikanth and Kenneth R. Olson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cancer Research.

In The Last Decade

Ravinder Kodela

48 papers receiving 1.5k citations

Peers

Ravinder Kodela
Mitali Chattopadhyay United States
Gui‐Zhen Ao China
Steven R. Woodcock United States
Liangwei Zhong China
Toshimasa Itoh Japan
G. Waeg Austria
Zhizhong Xie China
Rosa Amoroso Italy
Mario Cappiello Italy
Mitali Chattopadhyay United States
Ravinder Kodela
Citations per year, relative to Ravinder Kodela Ravinder Kodela (= 1×) peers Mitali Chattopadhyay

Countries citing papers authored by Ravinder Kodela

Since Specialization
Citations

This map shows the geographic impact of Ravinder Kodela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravinder Kodela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravinder Kodela more than expected).

Fields of papers citing papers by Ravinder Kodela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravinder Kodela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravinder Kodela. The network helps show where Ravinder Kodela may publish in the future.

Co-authorship network of co-authors of Ravinder Kodela

This figure shows the co-authorship network connecting the top 25 collaborators of Ravinder Kodela. A scholar is included among the top collaborators of Ravinder Kodela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravinder Kodela. Ravinder Kodela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chattopadhyay, Mitali, et al.. (2024). NOSH-aspirin (NBS-1120) inhibits estrogen receptor–negative breast cancer in vitro and in vivo by modulating redox-sensitive signaling pathways. Journal of Pharmacology and Experimental Therapeutics. 392(1). 100019–100019. 2 indexed citations
2.
Chattopadhyay, Mitali, et al.. (2020). NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS. Biochemical Pharmacology. 176. 113857–113857. 19 indexed citations
3.
Kodela, Ravinder, et al.. (2015). Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling. SHILAP Revista de lepidopterología. 5 indexed citations
4.
Kashfi, Khosrow, et al.. (2015). Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling. Drug Design Development and Therapy. 9. 4873–4873. 26 indexed citations
5.
6.
Vannini, Federica, Ravinder Kodela, Mitali Chattopadhyay, & Khosrow Kashfi. (2015). NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism. Redox Biology. 5. 421–421. 6 indexed citations
7.
Chattopadhyay, Mitali, et al.. (2013). Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression. Leukemia Research. 37(10). 1302–1308. 18 indexed citations
8.
Kodela, Ravinder, Mitali Chattopadhyay, Satindra Goswami, et al.. (2013). Positional Isomers of Aspirin Are Equally Potent in Inhibiting Colon Cancer Cell Growth: Differences in Mode of Cyclooxygenase Inhibition. Journal of Pharmacology and Experimental Therapeutics. 345(1). 85–94. 9 indexed citations
9.
Kodela, Ravinder, Mitali Chattopadhyay, & Khosrow Kashfi. (2013). Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential. MedChemComm. 4(11). 1472–1472. 38 indexed citations
10.
Chattopadhyay, Mitali, Ravinder Kodela, Kenneth R. Olson, & Khosrow Kashfi. (2012). NOSH–aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochemical and Biophysical Research Communications. 419(3). 523–528. 107 indexed citations
11.
Chattopadhyay, Mitali, et al.. (2011). Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochemical Pharmacology. 83(6). 723–732. 88 indexed citations
12.
Kodela, Ravinder, Mitali Chattopadhyay, Niharika Nath, et al.. (2011). Synthesis and biological activity of acetyl-protected hydroxybenzyl diethyl phosphates (EHBP) as potential chemotherapeutic agents. Bioorganic & Medicinal Chemistry Letters. 21(23). 7146–7150. 4 indexed citations
13.
Chaudhary, Ketul R., et al.. (2010). Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury. British Journal of Pharmacology. 162(4). 897–907. 63 indexed citations
14.
Nath, Niharika, Mitali Chattopadhyay, Satindra Goswami, et al.. (2010). JS-K; a nitric oxide-releasing prodrug, modulates β-catenin/TCF signaling in leukemic Jurkat cells: Evidence of an S-nitrosylated mechanism. Biochemical Pharmacology. 80(11). 1641–1649. 27 indexed citations
15.
Nath, Niharika, Mitali Chattopadhyay, Ravinder Kodela, et al.. (2010). Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells. Biochemical Pharmacology. 79(12). 1759–1771. 5 indexed citations
16.
Chattopadhyay, Mitali, Satindra Goswami, Ravinder Kodela, et al.. (2010). NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation. Cancer Letters. 298(2). 204–211. 42 indexed citations
17.
Falck, John R., Ravinder Kodela, P. Narender, et al.. (2009). 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble Epoxide Hydrolase Inhibition. Journal of Medicinal Chemistry. 52(16). 5069–5075. 74 indexed citations
18.
Reddy, A. Vijender, Ravinder Kodela, M. Narasimhulu, et al.. (2006). New anticancer bastadin alkaloids from the sponge Dendrilla cactos. Bioorganic & Medicinal Chemistry. 14(13). 4452–4457. 29 indexed citations
19.
Reddy, V. L. Niranjan, Gandikota Venkataramana, Ravinder Kodela, et al.. (2004). New Lamellarin Alkaloids from the Indian Ascidian Didemnum obscurum and Their Antioxidant Properties. Journal of Natural Products. 67(7). 1168–1171. 88 indexed citations
20.
Ravikanth, V., et al.. (2003). Three New Ingol Diterpenes from Euphorbia nivulia: Evaluation of Cytotoxic Activity.. Chemical and Pharmaceutical Bulletin. 51(4). 431–434. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitali Chattopadhyay Breakdown of academic impact, for papers by Gui‐Zhen Ao Breakdown of academic impact, for papers by Steven R. Woodcock Breakdown of academic impact, for papers by Liangwei Zhong Breakdown of academic impact, for papers by Toshimasa Itoh Breakdown of academic impact, for papers by G. Waeg Breakdown of academic impact, for papers by Zhizhong Xie Breakdown of academic impact, for papers by Rosa Amoroso Breakdown of academic impact, for papers by Mario Cappiello
Rankless by CCL
2026